Delivery Order SPE2DB20D2002-SPE2DB25FL25P

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BOOSTRIX TDAP vaccine syringes, a critical pharmaceutical product used to support military and government healthcare programs. The firm-fixed-price delivery order has a ceiling value of $2,554.30 and an ultimate completion date of September 19, 2024. This award is part of a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,556.52 and runs through March 7, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $63,270.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the delivery of BOOSTRIX TDAP vaccine syringes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,689.83, is for the delivery of BOOSTRIX TDAP vaccine syringes in 0.5 mL doses. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,635.88, is for the procurement of Boostrix TDAP vaccine syringes. The contract is a Firm Fixed Price arrangement with a performance period that runs through November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award, valued at $11,686.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Boostrix TDAP vaccine syringes. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a final completion date of August 5, 2024. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,998.40, is a Firm Fixed Price Delivery Order for the supply of BOOSTRIX TDAP Vaccine Syringes (0.5ML) to support military and federal healthcare programs. The contract has an ultimate completion date of January 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,661.00 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support federal healthcare programs. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,842.68 firm-fixed-price delivery order is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a performance period ending on January 9, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,052.50, is for the delivery of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a completion date of November 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen holds a larger Indefinite Delivery...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB25FL25P
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,610.00, is for the delivery of BOOSTRIX TDAP vaccine syringes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for DLA Troop Support Medical to procure a comprehensive range of pharmaceutical products and medical supplies for military healthcare programs globally. The contract has a period of performance through March 7, 2025 and uses a Firm Fixed Price pricing type. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/5/25, 10:08 AM